Recursion Pharmaceuticals-a Earnings

Recursion Pharmaceuticals-a’s revenue jumped 6.89% since last year same period to $14.75Mn in the Q1 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 226.87% jump in its revenue since last 3-months.

Recursion Pharmaceuticals-a’s net profit fell -121.6% since last year same period to $-202.49Mn in the Q1 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated -13.18% fall in its net profits since last 3-months.

Recursion Pharmaceuticals-a’s net profit margin fell -107.31% since last year same period to -1373.26% in the Q1 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 65.37% jump in its net profit margins since last 3-months.

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a 7.6% jump from last quarter’s estimates.

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current year stand at -0.32.

Recursion Pharmaceuticals-a’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Recursion Pharmaceuticals-a has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.